New research conducted by Trinity College Dublin, St. Vincent's Hospital and Harvard University may prove pivotal in the battle against obesity.
It has found that a type of anti-tumour immune cell protects against obesity and the metabolic syndrome that leads to diabetes.
The team also discovered that a lipid called "aGC" can lead to a dramatic improvement in metabolism, weight loss, and fatty liver disease, and can reverse diabetes by bolstering cells that have been depleted.